| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 02/20/2014 | US20140051720 N-Cyclobutyl - Imidazopyridine - Methylamine As TRPV1 Antagonists |
| 02/20/2014 | US20140051719 Selective Glycosidase Inhibitors and Uses Thereof |
| 02/20/2014 | US20140051711 Compounds that modulate intracellular calcium |
| 02/20/2014 | US20140051702 Use of Aminoindane Compounds in Treating Overactive Bladder and Interstitial Cystitis |
| 02/20/2014 | US20140051701 Methods of treating a disease or condition of the central nervous system |
| 02/20/2014 | US20140051695 Novel inhibitor compounds of phosphodiesterase type 10a |
| 02/20/2014 | US20140051689 Polycyclic Agents for the Treatment of Respiratory Syncytial Virus Infections |
| 02/20/2014 | US20140051681 Mst1 kinase inhibitors and methods of their use |
| 02/20/2014 | US20140051680 Histone Deacetylase Inhibitors |
| 02/20/2014 | US20140051677 Novel compound useful for the treatment of degenerative and inflammatory diseases |
| 02/20/2014 | US20140051672 1,4-disubstituted pyridazine analogs there of and methods for treating smn-deficiency-related conditions |
| 02/20/2014 | US20140050793 Novel Compositions for Inhibiting Virus Entry and Promoting Virolysis, and Methods Thereof |
| 02/20/2014 | US20140050783 Methods and compositions for sleep disorders and other disorders |
| 02/20/2014 | DE102012016908A1 Tris-(Hetero)Aryl-Pyrazole und ihre Verwendung Tris (hetero) aryl pyrazoles and their use |
| 02/19/2014 | EP2698368A1 Novel pyrazole derivative |
| 02/19/2014 | EP2697226A1 Compounds for electronic devices |
| 02/19/2014 | EP2697225A1 Materials for electronic devices |
| 02/19/2014 | EP2697224A1 Naphthalene-diimide-heterocycle-naphthalene diimide oligomers as organic semiconductors and transistors therefrom |
| 02/19/2014 | EP2697223A1 7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin d2 receptor modulators |
| 02/19/2014 | EP2697222A1 Tri- and tetracyclic pyrazolo[3,4-b]pyridine compounds as antineoplastic agent |
| 02/19/2014 | EP2697221A1 N- cyclobutyl - imidazopyridine - methylamine as trpv1 antagonists |
| 02/19/2014 | EP2696937A1 Thioamide, amidoxime and amidrazone derivatives as hiv attachment inhibitors |
| 02/19/2014 | CN103597053A Novel compounds and organic electronic device using same |
| 02/19/2014 | CN103596952A Substituted pyridopyrazines as novel Syk inhibitors |
| 02/19/2014 | CN103596951A 8-ethyl-6-(aryl)pyrido [2,3-d]pyrimidin-7(8h)-ones for the treatment of nervous system disorders and cancer |
| 02/19/2014 | CN103596950A Novel compound with amyloid affinity |
| 02/19/2014 | CN103596949A Compounds for treatment of metabolic syndrome |
| 02/19/2014 | CN103596926A Fused tricyclic compounds as RAF kinase inhibitors |
| 02/19/2014 | CN103588792A Pyrazolopyrimidine or pyrimidinopyrimidine compounds, preparation method therefor, pharmaceutical compositions thereof and applications thereof |
| 02/19/2014 | CN103588774A Clean technology for extracting tabersonine from Voacanga chalotiana Pierre ex Stapf |
| 02/19/2014 | CN103588773A Method for extracting and separating cytisine |
| 02/19/2014 | CN103588772A Preparation method of moxifloxacin intermediate |
| 02/19/2014 | CN103588771A Pyrimidine antitumor compound with Hedgehog antagonist activity |
| 02/19/2014 | CN101687763B Photocrosslinkable materials comprising alicyclic group |
| 02/18/2014 | US8653268 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 02/18/2014 | US8653097 Tetra-aza-heterocycles as phosphatidylinositol-3-kinases (P13-kinases) inhibitor |
| 02/18/2014 | US8653092 Tetrahydro-pyrido-pyrimidine derivatives |
| 02/18/2014 | US8653091 Pyrid-2yl fused heterocyclic compounds, and compositions and uses thereof |
| 02/18/2014 | US8653065 Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder |
| 02/18/2014 | CA2716706C Compounds and compositions as tlr activity modulators |
| 02/18/2014 | CA2701594C Heterocycle phenyl amide t-type calcium channel antagonists |
| 02/13/2014 | WO2014025854A1 Piperidine amide derivatives as hiv attachment inhibitors |
| 02/13/2014 | WO2014025852A1 Tricyclic alkene derivatives as hiv attachment inhibitors |
| 02/13/2014 | WO2014025850A1 Tricyclic amidine derivatives as hiv attachment inhibitors |
| 02/13/2014 | WO2014025114A1 Organic light-emitting compound and organic electroluminescent device using same |
| 02/13/2014 | WO2014024077A1 5-(1H-PYRAZOL-4-YL)-1H-PYRROLO[2,3-b]PYRIDINE DERIVATIVES AS KINASE INHIBITORS |
| 02/13/2014 | WO2014023815A1 New antibacterial compounds |
| 02/13/2014 | WO2014023814A1 New antibacterial compounds |
| 02/13/2014 | WO2014023390A2 (aza-)isoquinolinone derivatives |
| 02/13/2014 | WO2014023388A1 Materials for organic electroluminescence devices |
| 02/13/2014 | WO2014023385A1 Pyridopyrimidine derivatives as protein kinase inhibitors |
| 02/13/2014 | WO2014023083A1 PI3Kδ INHIBITOR |
| 02/13/2014 | US20140046067 Pharmacologically active alicyclic n,n'-substituted 3,7-diazabicyclo[3.3.1]nonane derivatives and drugs based thereon |
| 02/13/2014 | US20140046066 Process for the preparation of dpp-iv inhibitor |
| 02/13/2014 | US20140045882 Carboxamide, Sulfonamide and Amine Compounds and Methods for Using The Same |
| 02/13/2014 | US20140045879 Pharmaceutical Compositions for the Treatment of Capillary Arteriopathy |
| 02/13/2014 | US20140045875 Fused and Spirocycle Compounds and the Use Thereof |
| 02/13/2014 | US20140045872 17a-HYDROXYLASE/C17,20-LYASE INHIBITORS |
| 02/13/2014 | US20140045870 7-(Heteroaryl-Amino)-6,7,8,9-Tetrahydropyrido[1,2-A]Indol Acetic Acid Derivatives and Their Use as Prostaglandin D2 Receptor Modulators |
| 02/13/2014 | US20140045869 Dna-pk inhibitors |
| 02/13/2014 | US20140045864 Acid addition salts of risperidone and pharmaceutical compositions thereof |
| 02/13/2014 | US20140045859 Glucokinase Activators |
| 02/13/2014 | US20140045857 4-Methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalenes |
| 02/13/2014 | US20140045849 Pyrimidine derivatives for the treatment of viral infections |
| 02/13/2014 | US20140045840 Compounds and methods for kinase modulation, and indications therefor |
| 02/13/2014 | US20140045839 Novel anxiolytic compounds |
| 02/13/2014 | US20140045835 Triazolopyridine compounds as pim kinase inhibitors |
| 02/13/2014 | US20140045834 7-(3,5-Dimethyl-4-Isoxazolyl)-8-(Methyloxy)-1H-Imidazo[4,5-C]Quinoline Derivatives |
| 02/13/2014 | US20140045831 Bicyclic heterocycle compounds and their uses in therapy |
| 02/13/2014 | US20140045826 Methods and compositions for treating neurodegenerative diseases |
| 02/13/2014 | US20140045822 Kinase inhibitors and method of treating cancer with same |
| 02/13/2014 | US20140045819 Aldosterone synthase inhibitors |
| 02/13/2014 | US20140045817 Triazolopyridine compounds as pim kinase inhibitors |
| 02/13/2014 | US20140045816 Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors |
| 02/13/2014 | US20140045812 5-cyano-4- (pyrrolo [2,3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
| 02/13/2014 | US20140045793 Quinolone compound and pharmaceutical composition |
| 02/13/2014 | US20140045790 Novel Bicyclic Pyridinones |
| 02/12/2014 | EP2694517A1 Protein kinase inhibitors |
| 02/12/2014 | EP2694515A1 Protein kinase inhibitors |
| 02/12/2014 | EP2694504A2 8-ethyl-6-(aryl)pyrido [2,3-d]pyrimidin-7(8h)-ones for the treatment of nervous system disorders and cancer |
| 02/12/2014 | EP2694503A1 Substituted oligoazacarbazoles for light emitting diodes |
| 02/12/2014 | EP2694502A1 Substituted pyrimidinium compounds for combating animal pests |
| 02/12/2014 | EP2694501A1 2,9-dipyridyl-1,10-phenanthroline derivatives useful as actinide ligands, method for synthesizing same, and uses thereof |
| 02/12/2014 | EP2694500A1 Substituted imidazopyridines and intermediates thereof |
| 02/12/2014 | EP2694484A1 Pyrimidine derivatives for the treatment of viral infections |
| 02/12/2014 | EP2694480A1 Adamantyl compounds |
| 02/12/2014 | EP2694068A1 Pyridopyrazine derivatives and their use |
| 02/12/2014 | EP2694067A1 Pyridopyrazine derivatives and their use |
| 02/12/2014 | EP2693882A1 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment |
| 02/12/2014 | EP2693876A1 Substituted methylformyl reagents and method of using same to modify physicochemical and/or pharmacokinetic properties of compounds |
| 02/12/2014 | CN103582641A Nitrogen-containing aromatic compounds and organic electroluminescent elements |
| 02/12/2014 | CN103582640A Hydrazino 1H-imidazoquinolin-4-amines and conjugates made therefrom |
| 02/12/2014 | CN103582639A Substituted pyrimidinium compounds for combating animal pests |
| 02/12/2014 | CN103582637A Inhibitors of bruton's tyrosine kinase |
| 02/12/2014 | CN103582633A Nitrogenated heterocyclic compound and agricultural or horticultural bactericidal agent |
| 02/12/2014 | CN103582630A Neprilysin inhibitors |
| 02/12/2014 | CN103582496A Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom |
| 02/12/2014 | CN103582482A Pharmaceutically active disubstituted triazine derivatives |
| 02/12/2014 | CN103571502A Liquid crystal aligning agent and compound |
| 02/12/2014 | CN103570730A Condensed ring pyridazinone compound with bridge ring structure as well as preparation method and application thereof |